a new oral drug for leukemia called Tasigna
December 2007
You'll hear about a new oral drug for leukemia called Tasigna.
Tasigna (nilotinib) is an oral kinase inhibitor...similar to Gleevec (imatinib) or Sprycel (dasatinib).
Tasigna and Sprycel are for cases that are resistant to Gleevec.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote